T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 8.18 CNY
Market Cap: 15.9B CNY
Have any thoughts about
Tonghua Dongbao Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is 10.11 CNY. Compared to the current market price of 8.18 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is Undervalued by 19%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
10.11 CNY
Undervaluation 19%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation History
Tonghua Dongbao Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Tonghua Dongbao Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Tonghua Dongbao Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

8.18 CNY
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Tonghua Dongbao Pharmaceutical Co Ltd
CN
Pharmaceuticals
Market Cap
16.2B CNY
IPO
Aug 24, 1994
Employees
2 814
China
Market Cap
16.2B CNY
Industry
Pharmaceuticals
IPO
Aug 24, 1994
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Tonghua Dongbao Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Tonghua Dongbao Pharmaceutical Co Ltd.

What unique competitive advantages
does Tonghua Dongbao Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Tonghua Dongbao Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide P/S
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide P/E
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide P/OCF
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide P/FCFE
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide P/B
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide EV/S
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide EV/GP
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide EV/EBIT
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide EV/OCF
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide EV/FCFF
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide EV/IC
for Tonghua Dongbao Pharmaceutical Co Ltd.

Show me price targets
for Tonghua Dongbao Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Tonghua Dongbao Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Tonghua Dongbao Pharmaceutical Co Ltd?

What are the Net Income projections
for Tonghua Dongbao Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Tonghua Dongbao Pharmaceutical Co Ltd?

What are the EPS projections
for Tonghua Dongbao Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Tonghua Dongbao Pharmaceutical Co Ltd?

What are the EBIT projections
for Tonghua Dongbao Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Tonghua Dongbao Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Tonghua Dongbao Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Tonghua Dongbao Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Tonghua Dongbao Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Tonghua Dongbao Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Tonghua Dongbao Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Tonghua Dongbao Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Tonghua Dongbao Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide ROE
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide ROA
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide ROIC
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide ROCE
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide Gross Margin
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide Operating Margin
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide Net Margin
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide FCF Margin
for Tonghua Dongbao Pharmaceutical Co Ltd.

Show all solvency ratios
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide D/E Ratio
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide D/A Ratio
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide Quick Ratio
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide Current Ratio
for Tonghua Dongbao Pharmaceutical Co Ltd.

Provide Cash Ratio
for Tonghua Dongbao Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Tonghua Dongbao Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Tonghua Dongbao Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Tonghua Dongbao Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Tonghua Dongbao Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Tonghua Dongbao Pharmaceutical Co Ltd

Current Assets 2B
Cash & Short-Term Investments 512.4m
Receivables 652.6m
Other Current Assets 864.1m
Non-Current Assets 5B
Long-Term Investments 654.6m
PP&E 2.7B
Intangibles 1.4B
Other Non-Current Assets 256.7m
Current Liabilities 406.8m
Accounts Payable 132.7m
Accrued Liabilities 4m
Short-Term Debt 251.5m
Other Current Liabilities 18.6m
Non-Current Liabilities 146.5m
Long-Term Debt 107.5m
Other Non-Current Liabilities 39m
Efficiency

Earnings Waterfall
Tonghua Dongbao Pharmaceutical Co Ltd

Revenue
2.4B CNY
Cost of Revenue
-551.8m CNY
Gross Profit
1.9B CNY
Operating Expenses
-1.4B CNY
Operating Income
491.4m CNY
Other Expenses
-150.1m CNY
Net Income
341.3m CNY

Free Cash Flow Analysis
Tonghua Dongbao Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Tonghua Dongbao Pharmaceutical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

57/100
Profitability
Score

Tonghua Dongbao Pharmaceutical Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Tonghua Dongbao Pharmaceutical Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
82/100
Solvency
Score

Tonghua Dongbao Pharmaceutical Co Ltd's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Tonghua Dongbao Pharmaceutical Co Ltd

Wall Street analysts forecast Tonghua Dongbao Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Tonghua Dongbao Pharmaceutical Co Ltd is 11.26 CNY with a low forecast of 8.08 CNY and a high forecast of 14.7 CNY.

Lowest
Price Target
8.08 CNY
1% Downside
Average
Price Target
11.26 CNY
38% Upside
Highest
Price Target
14.7 CNY
80% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Tonghua Dongbao Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Tonghua Dongbao Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Tonghua Dongbao Pharmaceutical Co Ltd stock?

The intrinsic value of one Tonghua Dongbao Pharmaceutical Co Ltd stock under the Base Case scenario is 10.11 CNY.

Is Tonghua Dongbao Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 8.18 CNY, Tonghua Dongbao Pharmaceutical Co Ltd is Undervalued by 19%.

Back to Top